Psykofarmaka til patienter med glaukom

Karin Povlsen, Kenneth Skov, Miriam Kolko, Daniella Bach-Holm, Stig Ejdrup Andersen

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Abstract

This review offers a summary of the current knowledge of pshychotropic drugs and glaucoma. If exposed to psychotropic drugs, some patients may develop angle-closure glaucoma. Although rarely contraindicated, exposed predisposed and diagnosed patients should be followed-up by an ophthalmologist. It is still unclear if serotonin reuptake inhibitors increase the risk of angle-closure glaucoma. Tricyclic antidepressants and benzodiazepines should be used with caution in predisposed patients. The same applies to antipsychotic drugs, where first-generation antipsychotic drugs might have a smaller impact on the intraocular pressure than second-generation antipsychotic drugs.

Bidragets oversatte titelPsychotropic drugs for patients with glaucoma
OriginalsprogDansk
ArtikelnummerV03230141
Sider (fra-til)2245-2248
Antal sider4
TidsskriftUgeskrift for Laeger
Vol/bind185
Udgave nummer48
StatusUdgivet - 27 nov. 2023

Bibliografisk note

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Emneord

  • Antipsychotic Agents/adverse effects
  • Glaucoma, Angle-Closure/chemically induced
  • Glaucoma/chemically induced
  • Humans
  • Psychotropic Drugs
  • Selective Serotonin Reuptake Inhibitors/adverse effects

Fingeraftryk

Udforsk hvilke forskningsemner 'Psykofarmaka til patienter med glaukom' indeholder.

Citationsformater